NCT06299735Completed
Comparison of Airway Management With Bronchial Blocker and Double-Lumen Tube in Single-Lung Ventilation
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
In this study, the primary aim is to compare the impact of using a double-lumen tube and bronchial blocker for single-lung ventilation in patients undergoing minimal invasive cardiac surgeries on postoperative pulmonary functions. Secondary objectives include the comparison of application duration, success in lung collapse, and the number of repositioning attempts for both techniques.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 66 (actual)
- First submitted
- 6 Feb 2024
- Start date
- 17 Apr 2024
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Ankara City Hospital Bilkent
- Diseases
- Coronary artery disease
- NCT number
- NCT06299735
What you commit to
- Study type: Interventional
- Participants enrolled: 66
- From 17 Apr 2024 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Advanced-stage organ (heart, kidney, liver, lung) failure
- Advanced lung diseases (COPD, FEV1\<50%, restrictive lung diseases, history of chest surgery, Pulmonary Hypertension, PAB\>30mmHg)
Other
- Emergency surgeries
- Patients with ASA scores greater than 3
- Patients with anticipated difficult intubation
- Pregnant individuals
- Patients with a BMI greater than 40
- Patients lacking the ability to read, understand, sign the informed consent form, and those who do not wish to participate in the study
Who the study is looking for
- Patients planned for on-pump minimal invasive cardiac surgical procedures requiring single-lung ventilation
- Female and male patients aged 18 and above
- Patients with ASA scores of 1-2-3
- Patients with signed informed consent to participate in the study
- Patients with a Body Mass Index (BMI) less than 40
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ankara Bilkent City Hospital Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.